Does neuraxial anesthesia reduce 0-to-30-day mortality in patients undergoing surgery with an intermediate-to-high cardiac risk compared with general anesthesia?
Neuraxial anesthesia may offer a short-term mortality benefit over general anesthesia in patients with elevated cardiac risk undergoing surgery, though definitive large-scale RCTs are still needed.
Compared with general anesthesia, neuraxial anesthesia may reduce the 0-to-30-day mortality for patients undergoing a surgery with an intermediate-to-high cardiac risk (level of evidence moderate). Large randomized controlled trials on the difference in death and major outcomes between regional and general anesthesia are required.
Guay et al. (Sat,) studied this question.